logo

For the Inventor, By the Inventor

Muko, Japan

Nitto Pharmaceutical Industries, Ltd.


USPTO Granted Patents = 15


Trademarks = 5

Forward Citations = 15

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Yasunori Yonejima (10 out of 13 patents)

silverMedal Jun Ogawa (9 out of 39 patents)

bronzeMedal Shigenobu Kishino (9 out of 17 patents)

4.  Teruo Kawada (4 out of 7 patents)

5.  Nobuyuki Takahashi (4 out of 6 patents)

6.  Tsuyoshi Goto (4 out of 7 patents)

7.  Keiko Hisa (3 out of 4 patents)

8.  Sakayu Shimizu (2 out of 73 patents)

9.  Kenji Yamamoto (2 out of 8 patents)

10.  Chiaki Matsuzaki (2 out of 2 patents)

11.  Tatsuya Sugawara (2 out of 2 patents)

12.  Tsunataro Kishida (2 out of 5 patents)

13.  Yoshie Uchibori (1 out of 1 patent)

14.  Si-Bum Park (1 out of 1 patent)

15.  Hidekazu Kim (1 out of 1 patent)


15 patents:

1. 12697318 - ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID (2026-08-04),
2. 10952983 - Metabolism-improving agent comprising rare fatty acid (2021-03-23),
3. 10548868 - Metabolism-improving agent comprising rare fatty acid (2020-02-04),
4. 10507222 - Lactic acid bacterium and composition including said lactic acid bacterium (2019-12-17),
5. 10294501 - Method for producing oxo fatty acid and rare fatty acid (2019-05-21),
6. 10287234 - Triglyceride and use thereof (2019-05-14),
7. 10285966 - 10-hydroxy-cis-12-octadecenoic acid alkyl ester and use thereof (2019-05-14),
8. 10093749 - Exopolysaccharide produced by lactic acid bacterium (2018-10-09),
9. 9719115 - Method for producing oxo fatty acid and rare fatty acid (2017-08-01),
10. 9707200 - Metabolism-improving agent comprising rare fatty acid (2017-07-18),
11. 9572844 - Immunostimulation agent (2017-02-21),
12. 9539229 - Intestinal tract-protecting agent containing hydroxylated fatty acid (2017-01-10),
13. 6099833 - Method for inhibiting production of toxins from enteropathogenic (2000-08-08),
14. 5662900 - Method of increasing interferon production in humans (1997-09-02),
15. 5556785 - Lactobacillus used to enhance immunological functions (1996-09-17),
Company Overview
Nitto Pharmaceutical Industries, Ltd. is a prominent player in the pharmaceutical sector, specializing in the development and manufacturing of innovative medical products. The company focuses on therapeutic areas such as oncology, neurology, and infectious diseases, aiming to address unmet medical needs through advanced research and technology. Based in Muko, Japan, Nitto Pharmaceutical is committed to enhancing patient outcomes by leveraging cutting-edge science and fostering collaborations within the global healthcare community.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#1 in Muko

#3,443 in Japan

#39,921 in the World

Muko, JP
Muko, Japan

Nitto Pharmaceutical Industries, Ltd.

Forward Citations = 15

17 inventors:

goldMedal Yasunori Yonejima (10 out of 13 patents)

silverMedal Jun Ogawa (9 out of 39 patents)

bronzeMedal Shigenobu Kishino (9 out of 17 patents)

4.  Teruo Kawada (4 out of 7 patents)

5.  Nobuyuki Takahashi (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nitto Pharmaceutical Industries, Ltd.. Retrieved from https://idiyas.com/company/nitto-pharmaceutical-industries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…